Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates

Science Translational Medicine

Volumn 4, Issue 158, 2012, Pages

  Wong, Gary ^a,b   Richardson, Jason S ^a   Pillet, Stéphane ^a   Patel, Ami ^a,b   Qiu, Xiangguo ^a   Alimonti, Judie ^a   Hogan, Jeff ^c   Zhang, Yi ^d   Takada, Ayato ^e   Feldmann, Heinz ^b,f   Kobinger, Gary P ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF GEORGIA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e HOKKAIDO UNIVERSITY   (Japan)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; EBOLA VACCINE; IMMUNOGLOBULIN G; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FEMALE; GUINEA PIG; HOST SUSCEPTIBILITY; HUMORAL IMMUNITY; IMMUNE RESPONSE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RODENT; SURVIVAL; VACCINATION;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; EBOLAVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GUINEA PIGS; HEMORRHAGIC FEVER, EBOLA; MICE; PRIMATES;

EID: 84868265780     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004582     Document Type: Article

References (47)

1. J. A. Wilson, C. M. Bosio, M. K. Hart, Ebola virus: The search for vaccines and treatments. Cell. Mol. Life Sci. 58, 1826-1841 (2001). (Pubitemid 33108772)
2. M. K. Hart, Vaccine research efforts for filoviruses. Int. J. Parasitol. 33, 583-595 (2003). (Pubitemid 36638539)
3. N. J. Sullivan, A. Sanchez, P. E. Rollin, Z. Y. Yang, G. J. Nabel, Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605-609 (2000).
4. N. J. Sullivan, T. W. Geisbert, J. B. Geisbert, L. Xu, Z. Y. Yang, M. Roederer, R. A. Koup, P. B. Jahrling, G. J. Nabel, Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424, 681-684 (2003). (Pubitemid 36987993)
5. A. Bukreyev, P. E. Rollin, M. K. Tate, L. Yang, S. R. Zaki, W. J. Shieh, B. R. Murphy, P. L. Collins, A. Sanchez, Successful topical respiratory tract immunization of primates against Ebola virus. J. Virol. 81, 6379-6388 (2007). (Pubitemid 46878044)
6. A. Bukreyev, L. Yang, S. R. Zaki, W. J. Shieh, P. E. Rollin, B. R. Murphy, P. L. Collins, A. Sanchez, A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge. J. Virol. 80, 2267-2279 (2006). (Pubitemid 43271533)
7. L. Yang, A. Sanchez, J. M. Ward, B. R. Murphy, P. L. Collins, A. Bukreyev, A paramyxovirusvectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals. Virology 377, 255-264 (2008). (Pubitemid 351822376)
8. S. M. Jones, H. Feldmann, U. Ströher, J. B. Geisbert, L. Fernando, A. Grolla, H. D. Klenk, N. J. Sullivan, V. E. Volchkov, E. A. Fritz, K. M. Daddario, L. E. Hensley, P. B. Jahrling, T. W. Geisbert, Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 11, 786-790 (2005). (Pubitemid 41021212)
9. T. W. Geisbert, J. B. Geisbert, A. Leung, K. M. Daddario-DiCaprio, L. E. Hensley, A. Grolla, H. Feldmann, Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of Ebola virus. J. Virol. 83, 7296-7304 (2009).
10. Y. Yang, H. C. Ertl, J. M. Wilson, MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442 (1994).
11. Y. Yang, Q. Li, H. C. Ertl, J. M. Wilson, Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015 (1995).
12. Y. Yang, K. Greenough, J. M. Wilson, Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3, 412-420 (1996). (Pubitemid 26171339)
13. L. Xu, A. Sanchez, Z. Yang, S. R. Zaki, E. G. Nabel, S. T. Nichol, G. J. Nabel, Immunization for Ebola virus infection. Nat. Med. 4, 37-42 (1998). (Pubitemid 28133077)
14. P. Pushko, M. Bray, G. V. Ludwig, M. Parker, A. Schmaljohn, A. Sanchez, P. B. Jahrling, J. F. Smith, Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19, 142-153 (2000). (Pubitemid 30618964)
15. J. A. Wilson, M. K. Hart, Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein. J. Virol. 75, 2660-2664 (2001). (Pubitemid 32185029)
16. M. Gupta, S. Mahanty, M. Bray, R. Ahmed, P. E. Rollin, Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J. Virol. 75, 4649-4654 (2001). (Pubitemid 32381506)
17. K. L. Warfield, D. L. Swenson, G. G. Olinger, W. V. Kalina, M. J. Aman, S. Bavari, Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. J. Infect. Dis. 196 (Suppl. 2), S430-S437 (2007). (Pubitemid 351417291)
18. N. J. Sullivan, L. Hensley, C. Asiedu, T. W. Geisbert, D. Stanley, J. Johnson, A. Honko, G. Olinger, M. Bailey, J. B. Geisbert, K. A. Reimann, S. Bao, S. Rao, M. Roederer, P. B. Jahrling, R. A. Koup, G. J. Nabel, CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nat. Med. 17, 1128-1131 (2011).
19. J. M. Dye, A. S. Herbert, A. I. Kuehne, J. F. Barth, M. A. Muhammad, S. E. Zak, R. A. Ortiz, L. I. Prugar, W. D. Pratt, Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl. Acad. Sci. U.S.A. 109, 5034-5039 (2012).
20. X. Qiu, J. Audet, G. Wong, S. Pillet, A. Bello, T. Cabral, J. E. Strong, F. Plummer, C. R. Corbett, J. B. Alimonti, G. P. Kobinger, Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4, 138ra81 (2012).
21. S. A. Plotkin, Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17, 1055-1065 (2010).
22. S. A. Plotkin, Vaccines: Correlates of vaccine-induced immunity. Clin. Infect. Dis. 47, 401-409 (2008).
23. M. Rao, M. Bray, C. R. Alving, P. Jahrling, G. R. Matyas, Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: Protection in mice requires CD4+ T cells. J. Virol. 76, 9176-9185 (2002). (Pubitemid 34919876)
24. K. L. Warfield, J. G. Perkins, D. L. Swenson, E. M. Deal, C. M. Bosio, M. J. Aman, W. M. Yokoyama, H. A. Young, S. Bavari, Role of natural killer cells in innate protection against lethal Ebola virus infection. J. Exp. Med. 200, 169-179 (2004). (Pubitemid 38982176)
25. N. J. Sullivan, J. E. Martin, B. S. Graham, G. J. Nabel, Correlates of protective immunity for Ebola vaccines: Implications for regulatory approval by the animal rule. Nat. Rev. Microbiol. 7, 393-400 (2009).
26. J. E. Lee, M. L. Fusco, A. J. Hessell, W. B. Oswald, D. R. Burton, E. O. Saphire, Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177-182 (2008). (Pubitemid 351969896)
27. Z. Y. Yang, H. J. Duckers, N. J. Sullivan, A. Sanchez, E. G. Nabel, G. J. Nabel, Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6, 886-889 (2000). (Pubitemid 30644746)
28. Z. Yang, R. Delgado, L. Xu, R. F. Todd, E. G. Nabel, A. Sanchez, G. J. Nabel, Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 279, 1034-1037 (1998). (Pubitemid 28113305)
29. S. B. Bradfute, K. L. Warfield, S. Bavari, Functional CD8+ T cell responses in lethal Ebola virus infection. J. Immunol. 180, 4058-4066 (2008).
30. G. G. Olinger, M. A. Bailey, J. M. Dye, R. Bakken, A. Kuehne, J. Kondig, J. Wilson, R. J. Hogan, M. K. Hart, Protective cytotoxic T-cell responses induced by Venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. J. Virol. 79, 14189-14196 (2005). (Pubitemid 41552717)
31. S. Baize, E. M. Leroy, M. C. Georges-Courbot, M. Capron, J. Lansoud-Soukate, P. Debré, S. P. Fisher-Hoch, J. B. McCormick, A. J. Georges, Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5, 423-426 (1999). (Pubitemid 29180581)
32. X. Qiu, J. B. Alimonti, P. L. Melito, L. Fernando, U. Ströher, S. M. Jones, Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin. Immunol. 141, 218-227 (2011).
33. X. Qiu, L. Fernando, P. L. Melito, J. Audet, H. Feldmann, G. Kobinger, J. B. Alimonti, S. M. Jones, Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLoS Negl. Trop. Dis. 6, e1575 (2012).
34. N. Wauquier, P. Becquart, C. Padilla, S. Baize, E. M. Leroy, Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl. Trop. Dis. 4, e837 (2010).
35. E. A. Clark, J. A. Ledbetter, How B and T cells talk to each other. Nature 367, 425-428 (1994).
36. S. Kaur, T. Kaur, N. Garg, S. Mukherjee, P. Raina, V. Athokpam, Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis. Parasitol. Res. 103, 1413-1419 (2008).
37. Y. Kurono, M. Yamamoto, K. Fujihashi, S. Kodama, M. Suzuki, G. Mogi, J. R. McGhee, H. Kiyono, Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J. Infect. Dis. 180, 122-132 (1999). (Pubitemid 29293926)
38. F. Mosca, E. Tritto, A. Muzzi, E. Monaci, F. Bagnoli, C. Iavarone, D. O'Hagan, R. Rappuoli, E. De Gregorio, Molecular and cellular signatures of human vaccine adjuvants. Proc. Natl. Acad. Sci. U.S.A. 105, 10501-10506 (2008).
39. J. M. Brewer, M. Conacher, C. A. Hunter, M. Mohrs, F. Brombacher, J. Alexander, Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4-or IL-13-mediated signaling. J. Immunol. 163, 6448-6454 (1999).
40. G. Gao, X. Zhou, M. R. Alvira, P. Tran, J. Marsh, K. Lynd, W. Xiao, J. M. Wilson, High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells. Gene Ther. 10, 1926-1930 (2003). (Pubitemid 37258640)
41. G. P. Kobinger, H. Feldmann, Y. Zhi, G. Schumer, G. Gao, F. Feldmann, S. Jones, J. M. Wilson, Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology 346, 394-401 (2006). (Pubitemid 43357883)
42. M. Bray, K. Davis, T. Geisbert, C. Schmaljohn, J. Huggins, A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 178, 651-661 (1998). (Pubitemid 28397211)
43. B. M. Connolly, K. E. Steele, K. J. Davis, T. W. Geisbert, W. M. Kell, N. K. Jaax, P. B. Jahrling, Pathogenesis of experimental Ebola virus infection in guinea pigs. J. Infect. Dis. 179 (Suppl. 1), S203-S217 (1999). (Pubitemid 29091404)
44. J. Q. Wu, N. D. Barabé, Y. M. Huang, G. A. Rayner, M. E. Christopher, F. L. Schmaltz, Pre-and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha. Virology 369, 206-213 (2007). (Pubitemid 350047475)
45. X. Qiu, L. Fernando, J. B. Alimonti, P. L. Melito, F. Feldmann, D. Dick, U. Ströher, H. Feldmann, S. M. Jones, Mucosal immunization of cynomolgus macaques with the VSVDG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS One 4, e5547 (2009).
46. P. B. Jahrling, T. W. Geisbert, J. B. Geisbert, J. R. Swearengen, M. Bray, N. K. Jaax, J. W. Huggins, J. W. LeDuc, C. J. Peters, Evaluation of immune globulin and recombinant interferon-a2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179 (Suppl. 1), S224-S234 (1999). (Pubitemid 29091406)
47. E. Nakayama, A. Yokoyama, H. Miyamoto, M. Igarashi, N. Kishida, K. Matsuno, A. Marzi, H. Feldmann, K. Ito, M. Saijo, A. Takada, Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies. Clin. Vaccine Immunol. 17, 1723-1728 (2010).